Vertex (VERX) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.10 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 14.29%. A quarter ago, it was expected that this company would post earnings of $0.13 per share when it actually produced earnings of $0.15, delivering a surprise of 15.38%.Over the last four quarters, the company has surpa ...

Exhibit 99.1 Vertex Announces Third Quarter 2024 Financial Results KING OF PRUSSIA, PA – November 6, 2024: Vertex, Inc. (NASDAQ: VERX) ("Vertex" or the "Company"), a leading global provider of indirect tax solutions, today announced financial results for its third quarter ended September 30, 2024. "The third quarter of 2024 was another great quarter for Vertex", stated David DeStefano, Vertex's President, Chief Executive Officer and Chairperson of the Board. "Revenue was above the high end of our quarterly ...

KING OF PRUSSIA, Pa., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX) (“Vertex” or the “Company”), a leading global provider of indirect tax solutions, today announced financial results for its third quarter ended September 30, 2024. “The third quarter of 2024 was another great quarter for Vertex”, stated David DeStefano, Vertex’s President, Chief Executive Officer and Chairperson of the Board. “Revenue was above the high end of our quarterly guidance, with mid-teens organic revenue growth. We ...

I publish my best ideas and top coverage on the Growth Stock Forum . If you're interested in finding great growth stocks, with a focus on biotech, consider signing up. We focus on attractive risk/reward situations and track each of our portfolio and watchlist stocks closely. To receive e-mail notifications for my public articles and blogs, please click the follow button . And to go deeper, sign up for a free trial to Growth Stock Forum.Shares of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX ) have appre ...

We expect Vertex Pharmaceuticals Incorporated (VRTX) to surpass expectations when it reports third-quarter 2024 results on Nov. 4, after market close.The Zacks Consensus Estimate for the to-be-reported quarter’s revenues is pegged at $2.68 billion, while the same for earnings is pinned at $4.13 per share.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.Let's see how things might have shaped up for the quarter to be reported.Factors Shaping VRTX's Upcoming ResultsVertex currently mark ...

Its latest report of clinical data suggests it has a winner on its hands.Every big pharma company relies on a roster of just a few blockbuster drugs -- medicines that reliably bring in more than $1 billion in revenue every year -- to fund its core efforts, and to deliver solid returns to investors. So when a business like Vertex Pharmaceuticals (VRTX -1.02%) releases some new data on a potential blockbuster that could be just a few months away from being approved for sale, it's a big development.On that not ...

KING OF PRUSSIA, Pa., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ:VERX), a leading global technology provider of indirect tax solutions, today announced that it will release third quarter 2024 financial results before the market opens on Wednesday, November 6, 2024. A conference call to discuss the results will be held at 8:30 a.m. Eastern Time that same day. Those wishing to participate may do so by dialing 1-412-317-6026 approximately ten minutes prior to start time. A listen-only webcast of th ...

Vertex (NASDAQ: VRTX ) has a blossoming pipeline and continues to execute well. This article examines three commercial or nearly commercial products and the launch dynamics. While there may be volatility in share price, Vertex has a quality, maturing pipeline and a path Analyst's Disclosure: I/we have a beneficial long position in the shares of VRTX either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation fo ...

Overview of Vanguard's Recent Transaction On September 30, 2024, Vanguard Group Inc, a prominent investment firm, expanded its portfolio by acquiring an additional 334,189 shares of Vertex. Inc (VERX, Financial), a leading tax technology provider. This transaction increased Vanguard's total holdings in Vertex to 6,721,315 shares, reflecting a significant endorsement of Vertex's market position and business model. The shares were purchased at a price of $38.51, marking a strategic addition to Vanguard's dive ...

Vertex (VERX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices. The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system. Sin ...